Creative Diagnostics announces the launch of Products for Renal Metabolism. NEW YORK, NY, UNITED STATES, February 10, ...
NEW YORK, NY, UNITED STATES, January 30, 2026 /EINPresswire.com/ -- Creative Bioarray, one of the leading providers of ...
Axion BioSystems’ Letter of Intent for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular ...
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
BOSTON, MA, UNITED STATES, February 2, 2026 /EINPresswire.com/ -- TheraDep Technologies Inc today announced an ...
VivaMed BioPharma and CRDMO Syngene International are partnering on AI-powered discovery to bolster VivaMed’s validation infrastructure.
Devonian Health Group Inc. ("Devonian" or the Company) today announced that a proprietary Thykaminetm fingerprint has been formally filed in two recent patent applications and is now a core component ...
VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results